ArticleLife (Basel, Switzerland)2026

Adjunctive Use of VGH4 for Moderate-to-Severe Atopic Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Crossover Pilot Trial.

Ying-Ju Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.